Risk associations of melanoma in a Southern European population: results of a case/control study

[1]  A. Stratigos,et al.  Melanoma/skin cancer screening in a Mediterranean country: results of the Euromelanoma Screening Day Campaign in Greece , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  C. Garbe,et al.  Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden‐Württemberg) , 2006, The British journal of dermatology.

[3]  A. Tosca,et al.  The incidence of cutaneous melanoma on Crete, Greece , 2004, International journal of dermatology.

[4]  J. Lang.  Development of Prognostic Factors and Survival in Cutaneous Melanoma Over 25 Years: An Analysis of the Central Malignant Melanoma Registry of the German Dermatological Society , 2006 .

[5]  L. Naldi,et al.  Sun Exposure, Phenotypic Characteristics, and Cutaneous Malignant Melanoma. An Analysis According to Different Clinico-Pathological Variants and Anatomic Locations (Italy) , 2005, Cancer Causes & Control.

[6]  E. Rallis,et al.  Increasing incidence of melanoma in central Greece: a retrospective epidemiological study. , 2005, International journal of tissue reactions.

[7]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. , 2005, European journal of cancer.

[8]  Despina Ioannidou,et al.  Epidemiological differences for cutaneous melanoma in a relatively dark-skinned Caucasian population with chronic sun exposure. , 2004, European journal of cancer.

[9]  J. Coebergh,et al.  Cutaneous malignant melanoma in Europe. , 2004, European journal of cancer.

[10]  R. Westendorp,et al.  Solar lentigines are strongly related to sun exposure in contrast to ephelides. , 2004, Pigment cell research.

[11]  S. Chimenti,et al.  Constitutional and environmental risk factors for cutaneous melanoma in an Italian population. A case–control study , 2004, Melanoma research.

[12]  M. Lens,et al.  Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma , 2004, The British journal of dermatology.

[13]  L. Dennis,et al.  Sunscreen Use and the Risk for Melanoma: A Quantitative Review , 2003, Annals of Internal Medicine.

[14]  N. Hayward,et al.  Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. , 2003, Journal of the National Cancer Institute.

[15]  C. Garbe,et al.  Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood , 2003, Cancer.

[16]  S. Bastuji‐Garin,et al.  Cutaneous malignant melanoma, sun exposure, and sunscreen use: epidemiological evidence , 2002, The British journal of dermatology.

[17]  L. Naldi,et al.  The epidemiology of skin cancer , 2002, The British journal of dermatology.

[18]  A. Blum,et al.  Epidemiology of Cutaneous Melanoma in Germany and Worldwide , 2001, Skin Pharmacology and Physiology.

[19]  M T Landi,et al.  Combined risk factors for melanoma in a Mediterranean population , 2001, British Journal of Cancer.

[20]  N Cascinelli,et al.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  L. Naldi,et al.  Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population , 2000, Cancer.

[22]  M. Bigby.  The sunscreen and melanoma controversy. , 1999, Archives of dermatology.

[23]  M. González-Barón,et al.  Cutaneous malignant melanoma and sun exposure in Spain. , 1999, Melanoma research.

[24]  H. Soyer,et al.  Ultraviolet light exposure, pigmentary traits and the development of melanocytic naevi and cutaneous melanoma. A case-control study of the German Central Malignant Melanoma Registry. , 1997, Acta dermato-venereologica.

[25]  A Halpern,et al.  Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. , 1997, JAMA.

[26]  D. Easton,et al.  Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case‐control studies , 1995 .

[27]  A. Biggeri,et al.  Malignant melanoma in Italy: risks associated with common and clinically atypical melanocytic nevi. , 1995, Journal of the American Academy of Dermatology.

[28]  L. Garfinkel,et al.  Occupation and the risk of malignant melanoma. , 1995, Cancer.

[29]  D. Moore,et al.  Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi. , 1994, Archives of dermatology.

[30]  H. Soyer,et al.  Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. , 1994, The Journal of investigative dermatology.

[31]  H. Soyer,et al.  Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. , 1994, The Journal of investigative dermatology.

[32]  E. White,et al.  Case-control study of malignant melanoma in Washington State. I. Constitutional factors and sun exposure. , 1994, American journal of epidemiology.

[33]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[34]  C. Garbe,et al.  Markers and Relative Risk in a German Population for Developing Malignant Melanoma , 1989, International journal of dermatology.

[35]  R. MacKie,et al.  PERSONAL RISK-FACTOR CHART FOR CUTANEOUS MELANOMA , 1989, The Lancet.

[36]  T. Fitzpatrick.  The validity and practicality of sun-reactive skin types I through VI. , 1988, Archives of Dermatology.

[37]  T. Fitzpatrick.  The validity and practicality of sun-reactive skin types I through VI. , 1988, Archives of dermatology.